Selecky Christobel 4
4 · ImmunityBio, Inc. · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Selecky Christobel
Director
Transactions
- Exercise/Conversion
Common Stock
2026-02-23$2.98/sh+25,000$74,500→ 25,000 total - Sale
Common Stock
[F1]2026-02-23$10.00/sh−25,000$250,000→ 0 total - Exercise/Conversion
Stock Option (right to buy)
[F2]2026-02-23−25,000→ 67,937 totalExercise: $2.98Exp: 2032-06-14→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2025.
- [F2]One hundred percent (100%) of the shares subject to the award vested on June 12, 2023, the date immediately preceding the 2023 annual meeting of stockholders.
Signature
/s/ Philip LoScalzo, as Attorney-in-Fact|2026-02-24